Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Articles by Molly Bowman
02.27.23 -- What's Contributing To The API Shortage?
Article | By Joseph Arcangelo, Sr., inSeption Group Large CRO partners tout expertise or experience based on past success. Pulling back the curtain on this “corporate memory” can reveal the inefficiency of “that’s the way it’s always been done” thinking. Article | By Amit Jogi, Ph.D., Syngene International Ltd.
02.23.23 -- What Is Contributing To The API Shortage?
By Anna Levchuk and Molly Bowman, Clarivate No, you can’t have your cake and eat it, too. In this case, your “cake” is a six-cents-worth generic pill. We have seen a precarious competitive situation with generic drug manufacturing for several years now; what are the key trends and their impacts on the pharma supply chain? Let's investigate.
What Is Contributing To The API Shortage Original
By Anna Levchuk and Molly Bowman, Clarivate No, you can’t have your cake and eat it, too. In this case, your “cake” is a 6-cents-worth generic pill in your medicine cabinet. Governments of developed countries have sounded the alarm on the precarious competitive situation with generic drug manufacturing for several years now. At the same time, they cling to the illusion that it is possible to provide low-cost drugs and at the same time keep polluting industries beyond their borders.
Methodology for Establishing a Community-Wide Life Laboratory for Capturing Unobtrusive and Continuous Remote Activity and Health Data
Prevailing clinical research is fraught with limitations in the reliability and validity of data captured because of inherent shortcomings of assessment methodology. Interviews are constrained by the times when the clinician and patient can coordinate schedules. Time allotted for examinations is limited by what the volunteer can reasonably be asked to do in a single session.
Despite solid API market growth, India and China face challenges – including around costs - Clarivate
Companies have chosen India as a sourcing destination for many years due to India’s lower cost structure for manufacturing, labor, materials and equipment. India possesses a large talent pool of chemical engineers and scientists and a large manufacturing capacity focused on regulated markets. China also has a talented pool of scientists and engineers, a low cost base, better infrastructure than India, and also an improving GMP and patent protection environment.
18th Annual IGPA Conference: Global Market Dynamics for Generics & Biosimilars
Around the world economic factors are putting pressure on payers for prescription drugs. This in turn is putting pressure on prices, forcing all parts of the pharmaceutical supply chain to innovate in order to be sustainable. Jim Keon (IGPA & CGPA) opened the annual IGPA conference pointing out the savings achieved around the world by the increased use of generic medicines.
Show More
loading
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with Molly
Contact Molly, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack